Stemcells (STEM) Reports In-Line Q4 Loss of 13c/Share
Stemcells (NASDAQ: STEM) reported Q4 EPS of ($0.13), in-line ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
